In vitro maturation with letrozole priming: Can it be a solution for patients with cancerophobia? A pilot study | Zendy

Şafak Hatırnaz | Zendy; Ebru Hatırnaz | Zendy; Alper Başbuğ | Zendy; Mine KanatPektas | Zendy; Onur Erol | Zendy; Michael H. Dahan | Zendy; Seang Lin Tan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

<i>In vitro</i> maturation with letrozole priming: Can it be a solution for patients with cancerophobia? A pilot study

Author(s) -

Şafak Hatırnaz,

Ebru Hatırnaz,

Alper Başbuğ,

Mine KanatPektas,

Onur Erol,

Michael H. Dahan,

Seang Lin Tan

Publication year - 2020

Publication title -

journal of turkish society of obstetric and gynecology

Language(s) - English

Resource type - Journals

eISSN - 1307-7007

pISSN - 1307-699X

DOI - 10.4274/tjod.galenos.2020.79446

Subject(s) - letrozole , antral follicle , medicine , in vitro fertilisation , ovarian hyperstimulation syndrome , controlled ovarian hyperstimulation , germinal vesicle , infertility , ovarian reserve , andrology , priming (agriculture) , follicle stimulating hormone , endocrinology , gynecology , aromatase , hormone , biology , pregnancy , luteinizing hormone , oocyte , breast cancer , embryo , cancer , botany , germination , genetics , microbiology and biotechnology

To investigate whether letrozole priming could be used efficiently in patients undergoing in vitro maturation (IVM) as compared with follicle-stimulating hormone (FSH) priming.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research